What to Make of the FDA's Latest Warning to AbbVie and Pfizer

What to Make of the FDA's Latest Warning to AbbVie and Pfizer

Submitted by admin on December 18, 2021 - 10:56pm
Source: 
Motley Fool
News Tags: 
FDA
AbbVie
Pfizer
Rinvoq
Xeljanz
JAK inhibitors
Headline: 
What to Make of the FDA's Latest Warning to AbbVie and Pfizer
snippet: 
  • The FDA placed additional warnings on AbbVie's Rinvoq and Pfizer's Xeljanz.
  • Xeljanz received a tougher warning than Rinvoq did.
  • The worst-case scenario is that the FDA opts to restrict higher doses of the two JAK inhibitors.

Do Not Allow Advertisers to Use My Personal information